Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials (Q34263106)

1 August 2017

0 references

Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials (English)

1 reference

1 August 2017

1 reference

1 reference

4

Jill F F Belch

1 reference

1 August 2017

6

Ziyah Mehta

1 reference

1 August 2017

Peter M Rothwell

1

1 reference

1 August 2017

Michelle Wilson

series ordinal

2

1 reference

1 August 2017

Jacqueline F Price

series ordinal

3

1 reference

1 August 2017

Tom W Meade

series ordinal

5

1 reference

1 August 2017

language of work or name

English

0 references

publication date

21 March 2012

1 reference

1 August 2017

1 reference

1 August 2017

379

1 reference

1 August 2017

1591-1601

1 reference

1 August 2017

9826

1 reference

Global patterns of cancer incidence and mortality rates and trends

1 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960209-8

7 January 2021

Estimates of the cancer incidence and mortality in Europe in 2006.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960209-8

7 January 2021

Preventable cancer in the USA

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960209-8

7 January 2021

Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960209-8

7 January 2021

Aspirin, salicylates, and cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960209-8

7 January 2021

Aspirin and non-steroidal anti-inflammatory drugs for cancer prevention: an international consensus statement

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960209-8

7 January 2021

Aspirin and cancer risk: a summary review to 2007.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960209-8

7 January 2021

Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960209-8

7 January 2021

Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960209-8

7 January 2021

Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960209-8

7 January 2021

Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960209-8

7 January 2021

Antimetastatic effects associated with platelet reduction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960209-8

7 January 2021

Platelet—tumor-cell interactions in mice. The role of platelets in the spread of malignant disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960209-8

7 January 2021

The platelet contribution to cancer progression

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960209-8

7 January 2021

Contribution of platelets to tumour metastasis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960209-8

7 January 2021

Anti-metastatic effect of aspirin

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960209-8

7 January 2021

Suppression of lung metastasis by aspirin but not indomethacin in an in vivo model of chemically induced hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960209-8

7 January 2021

Nested case-control study of the effects of non-steroidal anti-inflammatory drugs on breast cancer risk and stage

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960209-8

7 January 2021

Aspirin intake and survival after breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960209-8

7 January 2021

Aspirin dose and duration of use and risk of colorectal cancer in men.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960209-8

7 January 2021

Aspirin use and survival after diagnosis of colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960209-8

7 January 2021

The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960209-8

7 January 2021

The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960209-8

7 January 2021

Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960209-8

7 January 2021

Biopharmaceutical characterisation of a low-dose (75 mg) controlled-release aspirin formulation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960209-8

7 January 2021

No effect of an antiaggregant treatment with aspirin in small cell lung cancer treated with CCAVP16 chemotherapy. Results from a randomized clinical trial of 303 patients. The "Petites Cellules" Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960209-8

7 January 2021

Use of nonsteroidal antiinflammatory drugs and risk of colon cancer in a population-based, case-control study of African Americans and Whites

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960209-8

7 January 2021

Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960209-8

7 January 2021

A preliminary study on the postoperative survival of patients given aspirin after resection for squamous cell carcinoma of the esophagus or adenocarcinoma of the cardia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960209-8

7 January 2021

Association of nonsteroidal anti-inflammatory drugs with lung cancer: results from a large cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960209-8

7 January 2021

Aspirin and non-small cell lung cancer resections: effect on long-term survival

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960209-8

7 January 2021

Low-dose aspirin and breast cancer risk: results by tumour characteristics from a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960209-8

7 January 2021

Cigarette smoking and the risk of pulmonary metastasis from breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960209-8

7 January 2021

Smoking is associated with worse outcomes in patients with prostate cancer treated by radical radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960209-8

7 January 2021

Effects of regular aspirin on long-term cancer incidence and metastasis: a systematic comparison of evidence from observational studies versus randomised trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2812%2960209-8

7 January 2021

10.1016/S0140-6736(12)60209-8

Identifiers

DOI

1 reference

1 August 2017

1 reference